Altesa Biosciences
PrivateLast Round
Series B
Feb 19, 2026
Total Funding Raised
$114M
Company Overview
Altesa BioSciences is a biotechnology company focused on developing antiviral drugs to combat globally significant diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Altesa Biosciences Comps
Public and private peers based on sector, stage, and business model.
Altesa Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 19, 2026 | ||||
| Series A | Jul 1, 2023 | ||||
| Seed | Jan 1, 2022 |
Altesa Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forbion Capital Partners | Series B |
| Forbion | Series B |
| Atlantic Partners | Series B |
| GRA Venture Fund | Series A, Seed |
| Medicxi | Series B, Series A |
| Pitango Venture Capital | Series B, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 19, 2026
$75M round completed.
- Sep 16, 2025
Partnered with BioMérieux for Phase IIb trial of vapendavir.
Altesa Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Altesa Biosciences's valuation, stock price, and market status.
